Precipio continues to sign new hemescreen™ customers

New haven, conn., sept. 28, 2023 (globe newswire) -- specialty cancer diagnostics company  precipio, inc.   (nasdaq: prpo) announced that new customer orders are expected to bring total q4 hemescreen revenues to an estimated $1.2m.
PRPO Ratings Summary
PRPO Quant Ranking